SCHEDULE: Vanguard Discloses 7.3% Stake in Cencora Inc.

Vanguard Capital Management has reported a beneficial ownership of 14,210,260 shares, representing 7.3% of Cencora Inc.'s common stock, as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, has filed a Schedule 13G indicating beneficial ownership of Cencora Inc. common stock.
• The filing reports a total of 14,210,260 shares owned, which constitutes 7.3% of the class of securities.
• Vanguard Capital Management has sole power to dispose of all 14,210,260 shares.
• The reporting entity is identified as an investment adviser and includes securities held by Vanguard funds and other managed accounts.
• The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. It confirms a significant institutional holding by a reputable firm, suggesting stability, but provides no new operational or financial performance data.

Positives

• Vanguard's significant stake suggests confidence in Cencora's long-term prospects, potentially attracting further institutional investment.
• The filing confirms Cencora Inc. is a significant holding for a major institutional investor like Vanguard.

Risks

• While not explicitly stated as a risk in this filing, a large institutional holder like Vanguard could potentially divest its stake, impacting share price.
• The filing does not contain forward-looking statements, so future performance risks are not detailed here.

Future Outlook

This filing is a Schedule 13G, which reports beneficial ownership and does not contain forward-looking statements or company guidance.

Management Comments

• "In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd."
• "This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power."
• "This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Cencora Inc. (formerly AmerisourceBergen) is a significant player in pharmaceutical distribution and related services. A substantial stake by Vanguard, a major global investment management corporation, indicates institutional confidence in the company's business model and market position within the healthcare supply chain industry.

Stakeholder Impact

• Shareholders: The significant stake held by Vanguard may be viewed positively, potentially indicating stability and institutional support, which could influence investor sentiment.
• Creditors: A large, stable institutional holder can be seen as a positive indicator of the company's financial stability.
• Employees and Suppliers: No direct impact is indicated by this filing.

Next Steps

• Vanguard will continue to hold or manage its stake in Cencora Inc. according to its investment strategies.
• Cencora Inc. will continue its operations as a pharmaceutical distributor and service provider.

Key Dates

Keywords

Cencora Inc, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Adviser